Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Ann Surg Oncol. 2023 Jul 22;30(11):6340–6352. doi: 10.1245/s10434-023-13935-0

Figure 2.

Figure 2.

Kaplan-meier curves for recurrence-free survival in patients with resected, pathologic stage III cutaneous melanoma stratified by time to adjuvant immune checkpoint inhibitors (ICI) within the multi-institutional cohort. A) Entire cohort; B) Conditional landmark analysis. C) Kaplan-meier curves for overall survival in patients with resected, pathologic stage III cutaneous melanoma stratified by time to adjuvant immunotherapy (IO) within the National Cancer Database (NCDB) cohort.